US Patent Issued to Regeneron Pharmaceuticals on May 13 for "Maytansinoid derivatives, conjugates thereof, and methods of use" (New York Inventor)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,207, issued on May 13, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Maytansinoid derivatives, conjugates thereof, and methods of use" was invented by Thomas Nittoli (Pearl River, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are maytansinoid derivatives, conjugates thereof, and methods of treating or preventing proliferative diseases with the same."

The patent was filed on Nov. 16, 2021, under Application No. 17/528,144.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&...